Lauren Brown
Psychiatric/Mental Health · Monett, MONPI 1588317978
Payments from drug & device makers
Across 192 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$445
- Supernus Pharmaceuticals, Inc.$385
- AbbVie$370
- Axsome Therapeutics, Inc.$269
- Alkermes, Inc.$236
- Corium, LLC$190
- plus $973 from 17 others
What the payments were for
- Food & beverage$2,862100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 31 | $445 |
| Supernus Pharmaceuticals, Inc. | 32 | $385 |
| AbbVie | 36 | $370 |
| Axsome Therapeutics, Inc. | 10 | $269 |
| Alkermes, Inc. | 11 | $236 |
| Corium, LLC | 14 | $190 |
| Teva Pharmaceuticals USA, Inc. | 12 | $179 |
| Sunovion Pharmaceuticals Inc. | 13 | $152 |
| Otsuka America Pharmaceutical, Inc. | 7 | $131 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $106 |
| Lundbeck LLC | 5 | $89 |
| Exact Sciences | 4 | $59 |
| Hologic Sales And Service, LLC | 2 | $36 |
| Johnson & Johnson | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| Boehringer Ingelheim | 2 | $28 |
| Bayer | 2 | $26 |
| Novo Nordisk | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Sanofi | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $13 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auvelity$125
How this compares
$2,867 in reported general payments places this provider in the 75th percentile of 565 psychiatric/mental health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 33 | $285,920 |
| Invega SustennaPaliperidone Palmitate | 52 | $172,365 |
| VraylarCariprazine Hcl | 101 | $146,267 |
| IngrezzaValbenazine Tosylate | 14 | $115,767 |
| RexultiBrexpiprazole | 69 | $98,289 |
| CaplytaLumateperone Tosylate | 55 | $93,909 |
| Abilify MaintenaAripiprazole | 14 | $39,483 |
| Lurasidone Hcl | 59 | $21,290 |
| TrintellixVortioxetine Hydrobromide | 23 | $11,706 |
| Chlorpromazine Hcl | 34 | $9,613 |
| Divalproex Sodium ErDivalproex Sodium | 68 | $6,164 |
| Aripiprazole | 97 | $5,226 |
| Quetiapine Fumarate | 158 | $5,031 |
| Olanzapine | 121 | $4,477 |
| Hydroxyzine Hcl | 199 | $3,996 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $179 | $285,92033 claims |
| Johnson & JohnsonInvega Sustenna | $33 | $172,36552 claims |
| AbbVieVraylar | $370 | $146,267101 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $131 | $137,77383 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $445 | $115,76714 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $31 | $11,70623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Monett
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
- Kelsey KingsboroughMexico$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.